Heterogeneous regional expression patterns of matrix metalloproteinases in human malignant gliomas

International Journal of Developmental Neuroscience

Volumn 17, Issue 5-6, 1999, Pages 437-445

  Vince, Giles H ^a   Wagner, Sven ^a   Pietsch, Torsten ^c   Klein, Rüdiger ^b   Goldbrunner, Roland H ^a   Roosen, Klaus ^a   Tonn, Jörg C ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Glioma; Heterogeneity; Invasion; Matrix metalloproteases

Indexed keywords

GELATINASE A; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; STROMELYSIN;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NORMAL HUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BRAIN NEOPLASMS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0032876809     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(99)00018-0     Document Type: Article

References (40)

1. Anthony D.C., Ferguson B., Matyzak M.K., Miller K.M., Esiri M.M., Perry V.H. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol. Appl. Neurobiol. 23:1997;406-415.
2. Bernstein J.J., Woodard C.A. Glioblastoma cells do not intravasate into blood vessels. Neurosurgery. 36:1995;124-132.
3. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell. Biol. 7:1995;728-735.
4. Borchers A.H., Sanders L.A., Bowden G.T. Regulation of matrilysin expression in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact. J. Cancer Res. Clin. Oncol. 123:1997;12-20.
5. Borden P., Heller R.A. Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit. Rev. Eukaryot. Gene Expr. 7:1997;159-178.
6. Bramhall S.R. The matrix metalloproteinases and their inhibitors in pancreatic cancer. Int. J. Pancreatol. 21:1997;1-12.
7. Costello P.C., Del Maestro R.F., Stetler-Stevenson W.G. Gelatinase A expression in human malignant gliomas. Ann. N. Y. Acad. Sci. 732:1994;450-452.
8. Cuvelier A., Kuntz C., Sesboué R., Muir J.F., Martin J.P. Les métalloprotéinases de la matrice extracellulaire (MMP): structure et activité Rev. Mal. Resp. 14:1997;1-10.
9. Ennis B.W., Matrisian L.M. Matrix degrading metalloproteinases. J. Neurooncol. 18:1994;105-109.
10. Goldbrunner R.H., Bernstein J.J., Plate K.H., Vince G.H., Roosen K., Tonn J.C. Vascularization of human glioma spheroids implanted into rat cortex. Anticancer Res. 17:1997;4036.
11. Heppner K.J., Matrisian L.M., Jensen R.A., Rodgers W.H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149:1996;273-282.
12. Himelstein B.P., Caneter-Soler R., Bernhard E.J., Dilks D.W., Muschel R.J. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis. 14:1994;246-258.
13. Kleihues P., Burger P.C., Scheithauer B.W. The new WHO classification of brain tumors. Brain Pathol. 3:1993;255-268.
14. Lampert K., Machein U., Machein M.R., Conca W., Peter H.H., Volk B. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am. J. Pathol. 153:1998;429-437.
15. Liotta L.A., Stetler-Stevenson W.G. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 51:1991;5054-5059.
16. Liotta L.A., Thorgeirsson U.P., Garbisa S. Role of collagenases in tumor cell invasion. Cancer Metastasis Rev. 1:1982;277-288.
17. Maeda A., Sobel R.A. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55:1996;300-309.
18. Maidment S.L., Merzak A., Koochekpour S., Rooprai H.K., Rucklidge G.J., Pilkington G.J. The effect of exogenous gangliosides on matrix metalloproteinase secretion by human glioma cells in vitro. Eur. J. Cancer. 32:1996;868-871.
19. Maidment S.L., Rucklidge G.J., Rooprai H.K., Pilkington G.J. An inverse correlation between expression of NCAM-A and the matrix-metalloproteinases gelatinase-A and gelatinase-B in human glioma cells in vitro. Cancer Lett. 116:1997;71-77.
20. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genet. 6:1990;121-125.
21. Matsuzawa K., Fukuyama K., Dirks P.B., Hubbard S.L., Murakami M., Becker L.E., Rutka J.T. Expression of stromelysin-1 in human glioma cell lines. J. Neurooncol. 30:1996;181-188.
22. Merzak A., Koochekpour S., McCrea S., Roxanis R., Pilkington G.J. Control of human glioma cell growth, migration and invasion by transforming growth factor β1. Br. J. Cancer. 70:1994;199-203.
23. Miyagi N., Kato S., Terasaki M., Shigemori M., Morimatsu M. Fibroblast growth factor-2 and -9 regulate proliferation and production of matrix metalloproteinases in human gliomas. Int. J. Oncol. 12:1998;1085-1090.
24. Nakagawa T., Kubota T., Kabuto M., Sato K., Kawano H., Hayakawa T., Okada Y. Production of matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 by human brain tumors. J. Neurosurg. 81:1994;69-77.
25. Nakano A., Tani E., Miyazaki K., Yamamoto Y., Furuyama J. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J. Neurosurg. 83:1995;298-307.
26. Noel A., Emonard H., Polette M, Birembaut P., Foidart J.M. Role of matrix, fibroblasts and type IV collagenases in tumor progression and invasion. Pathol. Res. Pract. 190:1994;934-941.
27. Paganetti P.A., Caroni P., Schwab M.E. Glioblastoma infiltration into central nervous system tissue in vitro: involvement of a metalloproteinase. J. Cell. Biol. 107:1988;2281-2291.
28. Rao J.S., Steck P.A., Mohanam S., Stetler-Stevenson W.G., Liotta L.A., Sawaya R. Elevated levels of M 92000 type IV collagenase in human brain tumors. Cancer Res. 53:1993;2208-2211.
29. Rao J.S., Yamamoto M., Mohanam S., Gokaslan Z.L., Fuller G.N., Stetler-Stevenson W.G., Rao V.H., Liotta L.A., Nicolson G.L. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin. Exp. Metastasis. 14:1996;12-18.
30. Romanic A.M., Madri J.A. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol. 4:1994;145-156.
31. Rooprai H.K., Van Meter T., Rucklidge G.J., Hudson L., Everall I.P., Pilkington G.J. Comparative analysis of matrix metalloproteinases by immunocytochemistry, immunohistochemistry and zymography in human primary brain tumours. Int. J. Oncol. 13:(6):1998;1153-1157.
32. Rutka J.T., Hubbard S.L., Fukuyama K., Matsuzawa K., Becker L.E., Stetler-Stevenson W.G., Dirks P.B. Expression of TIMP-1, TIMP-2, 72 and 92 kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with astrocytoma cell invasiveness. Int. J. Oncol. 6:1995;877-884.
33. Sawaya R.E., Yamamoto M., Gokaslan Z.L., Wang S.W., Mohanam S., Fuller G.N., McCutcheon I.E., Stetler-Stevenson W.G., Nicolson G.L. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin. Exp. Metastasis. 14:1996;35-42.
34. Shapiro S.D. Matrix Metalloproteinase degradation of extracellular matrix: biological consequences. Curr. Opin. Cell Biol. 10:1998;602-608.
35. Stetler-Stevenson W.G., Brown P.D., Onisto M., Levy A.T., Liotta L.A. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J. Biol. Chem. 265:1990;13933-13938.
36. Uhm J.H., Dooley N.P., Villemure J.G., Yong V.W. Mechanisms of glioma invasion: role of matrix-metalloproteinases. Can. J. Neurol. Sci. 24:1997;3-150.
37. Wagner S., Stegen C., Bouterfa H., Huettner C., Kerkau S., Roggendorf W., Roosen K., Tonn J.C. Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10. J. Neurooncol. 40:1998;113-122.
38. Wilson C.L., Heppner K.J., Labosky P.A., Hogan B.L.M., Matrisian L.M. Interstitial tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc. Natl. Acad. Sci. 94:1997;1402-1407.
39. Wojtowicz-Praga S.M., Dickson R.B., Hawkins M.J. Matrix metalloproteinase inhibitors. Invest. New Drugs. 15:1997;61-75.
40. Yamada T., Yoshiyama Y., Sato H., Seiki M., Shinagawa A., Takahashi M. White matter microglia produce membrane type matrix metalloproteinase, an activator of gelatinase-A, in human brain tissues. Acta Neuropathol. 90:1995;421-424.